Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Origin is a clinical-stage medical technology company focused on developing cold plasma-based therapies for a variety of medical and dental applications. The company's proprietary technology utilizes ionized gas at room temperature to deliver therapeutic effects, including the eradication of bacteria and the stimulation of tissue regeneration. Origin's primary clinical focus is on dermatology, podiatry, and dentistry, with lead programs targeting chronic wounds such as diabetic foot ulcers. By leveraging the unique properties of cold plasma, the company aims to provide non-invasive, antibiotic-free solutions for complex infections and inflammatory conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dental Origin.